Cochrane · systematic review · CD013169
Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea
Barbosa, FT, Silva, MP, Fontes, LES, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library
AirwaysAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
16
current version
GRADE rated
8
No studies
5
Included studies
NR
No studies 5 · 31.3%Ungraded 3 · 18.8%Very low 7 · 43.8%Low 1 · 6.3%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Continuous positive airway pressure (CPAP) compared to no CPAP for improving erectile dysfunction in men with obstructive sleep apnoea
Population: erectile dysfunction in men with obstructive sleep apnoea
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Erectile dysfunction Continuous positive airway pressure (CPAP) vs no CPAP | no estimate extracted | 1 study · 27 participants | Very low Downgraded: risk of bias, imprecision |
Erectile dysfunction Continuous positive airway pressure (CPAP) vs no CPAP | no estimate extracted | 1 study · 57 participants | Very low Downgraded: risk of bias, imprecision |
Serious adverse events Continuous positive airway pressure (CPAP) vs no CPAP | no estimate extracted | 1 study · 27 participants | Very low Downgraded: risk of bias |
Sex‐related quality of life (QoL) Continuous positive airway pressure (CPAP) vs no CPAP | no estimate extracted | 1 study · 57 participants | Very low Downgraded: risk of bias, imprecision |
Health‐related quality of life Continuous positive airway pressure (CPAP) vs no CPAP | no estimate extracted | NR | No studies |
Minor adverse events Continuous positive airway pressure (CPAP) vs no CPAP | no estimate extracted | NR | No studies |
Continuous positive airway pressure (CPAP) compared to sham CPAP for improving erectile dysfunction in men with obstructive sleep apnoea
Population: erectile dysfunction in men with obstructive sleep apnoea
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Erectile dysfunction Continuous positive airway pressure (CPAP) vs sham CPAP | no estimate extracted | 1 study · 61 participants | Ungraded |
Serious adverse events Continuous positive airway pressure (CPAP) vs sham CPAP | no estimate extracted | NR | No studies |
Sex‐related quality of life Continuous positive airway pressure (CPAP) vs sham CPAP | no estimate extracted | 1 study · 61 participants | Ungraded |
Health‐related quality of life Continuous positive airway pressure (CPAP) vs sham CPAP | no estimate extracted | 1 study · 61 participants | Ungraded |
Minor adverse events Continuous positive airway pressure (CPAP) vs sham CPAP | no estimate extracted | NR | No studies |
Continuous positive airway pressure (CPAP) compared to phosphodiesterase type 5 inhibitors for improving erectile dysfunction in men with obstructive sleep apnoea
Population: erectile dysfunction in men with obstructive sleep apnoea
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Erectile dysfunction Continuous positive airway pressure (CPAP) vs phosphodiesterase type 5 inhibitors | no estimate extracted | 3 studies · 152 participants | Low Downgraded: risk of bias |
Serious adverse events Continuous positive airway pressure (CPAP) vs phosphodiesterase type 5 inhibitors | no estimate extracted | 1 study · 40 participants | Very low Downgraded: risk of bias |
Sex‐related quality of life (QoL) Continuous positive airway pressure (CPAP) vs phosphodiesterase type 5 inhibitors | no estimate extracted | 2 studies · 122 participants | Very low Downgraded: risk of bias, imprecision |
Health‐related quality of life Continuous positive airway pressure (CPAP) vs phosphodiesterase type 5 inhibitors | no estimate extracted | NR | No studies |
Minor adverse events Continuous positive airway pressure (CPAP) vs phosphodiesterase type 5 inhibitors | RR 1.33 [0.34, 5.21] | 1 study · 40 participants | Very low Downgraded: risk of bias |